ACM Research, Inc. (ACMR) Stock Analysis
Is ACMR a good investment?
ACM Research, Inc. (ACMR) has a Plutrex AI rating of 74.0/100 as of November 12, 2026, indicating a Buy consensus. The stock is not classified as halal-compliant. Key strength: Cash fortress of $1.32B against ~$2.6B market cap means cash represents ~51% of market cap; with D/E of 0.08 (63.9% below industry average of 0.22), the company has multi-year runway with zero existential financial risk even at -$200M FCF/year. Main concern: P/E has expanded from 25.12x to 33.0x while stock moved only -1.1% (from $53.02 to $52.43) — this means EPS estimates have been revised DOWN materially, directly contradicting the 'double beat' narrative; worsening earnings quality combined with negative FCF deepening to -$200M (from -$120M) is the #1 fundamental red flag that could keep the stock range-bound despite cheap optrics.
Investment Summary
ACM Research (ACMR) at $52.43 represents a deeply discounted semiconductor equipment company with a genuinely compelling absolute valuation but a mixed relative standing. The stock has fallen ~70% from its highs entirely on sector sentiment/geopolitical concerns rather than fundamental deterioration — Q3 revenue grew 36.6% YoY with a double beat on both revenue and earnings, management raised full-year 2026 guidance, and the analyst consensus target has actually INCREASED from $118 to $136 (+15.3%) while the stock barely moved (-1.1%). On absolute valuation: PEG of 0.83 (below the 1.0 threshold indicating undervaluation), P/B of 1.96x (remarkably low for a growth tech company), and a $1.32B cash fortress against a ~$2.6B market cap means cash alone represents ~51% of market cap. The core bull case: at $52.43, cash-adjusted price ≈ $26/share on a company projecting 37.8% next-year EPS growth — that's a cash-adjusted PEG approaching 0.4x. Key concern: P/E has expanded from 25.12x to 33.0x while the stock barely moved, implying EPS estimates have been revised DOWN — a negative signal for earnings quality. The industry comparison remains unflattering (ROE 7% vs sector 55.7%, net margin 10.2% vs sector 44.9%), but ACMR is a capital equipment manufacturer, not a fabless chip designer, so direct margin comparisons overstate the gap. The stock is a 'show me' situation: fundamentally cheap, technically broken, news positive — conviction remains Medium.
Key Strengths
- Cash fortress of $1.32B against ~$2.6B market cap means cash represents ~51% of market cap; with D/E of 0.08 (63.9% below industry average of 0.22), the company has multi-year runway with zero existential financial risk even at -$200M FCF/year
- Analyst consensus target raised from $118 to $136 (+15.3%) in 14 days despite Q3 earnings — implies fundamental upgrade by sell-side, not just price target drift; Q3 double beat (revenue +36.6% YoY, EPS beat) with raised full-year 2026 guidance confirms management confidence and business momentum
- Absolute PEG of 0.83 and P/B of 1.96x on a company with 37.8% forward EPS growth and 36.6% revenue growth represents genuine growth-adjusted undervaluation; cash-adjusted P/E ≈ 18x on 37.8% EPS growth yields cash-adjusted PEG ≈ 0.48x — exceptional cheapness if earnings recover as projected
Key Concerns
- P/E has expanded from 25.12x to 33.0x while stock moved only -1.1% (from $53.02 to $52.43) — this means EPS estimates have been revised DOWN materially, directly contradicting the 'double beat' narrative; worsening earnings quality combined with negative FCF deepening to -$200M (from -$120M) is the #1 fundamental red flag that could keep the stock range-bound despite cheap optrics
- Technical momentum remains severely broken: stock down ~70% from highs, now at $52.43 sitting just above the prior $44 stop-loss reset level; China export control overhang has created persistent institutional selling pressure that strong Q3 results and raised guidance have been unable to reverse — the stock failed to react positively to good news, which is a bearish signal in itself
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
ACMR's fundamentals present a split picture. Profitability: Gross margin 43.5% (acceptable for equipment, but 28.3% below the semiconductor peer average of 60.7%), operating margin 14.5% (71.1% below peer average of 50.2%), net margin 10.2% (77.3% below peer average of 44.9%). ROE of 7.0% vs industry 55.7% is the most damning comparison (-87.4%), though notably the peer universe includes high-margin fabless companies that distort the average. Health: Debt-to-equity 0.08 vs industry 0.22 — ACMR is virtually debt-free and among the least leveraged in the sector. Cash of $1.32B provides 6+ years of FCF burn coverage at current -$200M/year rate. FCF remains negative at -$200M (worsened from -$120M prior report), which is the #1 quality concern — the company is growing revenue 36.6% but consuming cash, signaling heavy working capital and capex requirements. Growth: Revenue +36.6% YoY (solid in absolute terms but trails industry average of 107.2%), forward EPS growth 37.8% next year / 39.6% 5-year (both below industry averages of 54.4% / 60.7%). Historical EPS decline of -96.2% reflects a near-total earnings collapse that makes forward recovery projections look more dramatic than they may be on a normalized basis. Valuation: P/E 33.0x (up from 25.12x two weeks ago despite flat stock — implies EPS estimate revisions DOWN), PEG 0.83, P/B 1.96x. Analyst consensus target $136 implies 159% upside — unusually wide gap that cuts both ways.
News Sentiment
ACM Research is staging a quiet comeback story that Wall Street is only beginning to notice — but the stock price hasn't gotten the memo yet. The San Jose-based semiconductor equipment maker delivered a standout third quarter, beating expectations on both revenue and earnings, with sales surging 36.6% compared to the same period last year. Management was confident enough to raise its full-year 2026 guidance, a signal that demand from Chinese chip manufacturers buying homegrown equipment isn't slowing down. The 'ACMR Q3 Earnings Beat Estimates on ECP Growth, Revenues Rise Y/Y' headline tells the core story: ACM's electrochemical plating tools — used in advanced chip manufacturing — are selling briskly as China races to build domestic semiconductor capability. The 'ACMR Q3 Earnings Call Highlights Raised Outlook and Backlog Growth' report adds another layer: not only did the company beat last quarter, its order book is growing, providing revenue visibility into 2027. Perhaps most telling is 'ACM Research Q3: Risk-To-Reward Is Once Again Enticing After The Correction' — analysts who follow the stock closely are pointing to the 70% decline from highs as a buying opportunity, not a warning sign. The disconnect between ACM's strengthening business fundamentals and its beaten-down stock price comes down to one word: China. Despite strong earnings, investors remain nervous about potential US export restrictions. For patient investors who believe China's semiconductor buildout continues regardless of geopolitical friction, ACMR at ~$52 — trading at less than twice book value with $1.32 billion in cash — looks like a compelling long-term bet.
Risk Assessment
PRIMARY RISK: China export control escalation. ACMR derives a substantial portion of revenue from China semiconductor customers who are localization beneficiaries. Any incremental US export restrictions targeting ACMR's specific tool categories (ECP, SAPS, TEBO cleaning) would directly impair the revenue base and invalidate the growth thesis. This is binary and unpredictable — no fundamental analysis can hedge it. SECONDARY RISK: Earnings quality deterioration. The P/E expanding from 25x to 33x with a flat stock price means EPS estimates declined. If negative FCF (-$200M) deepens and EPS recovery stalls, the valuation floor could break below $44 support. TERTIARY RISK: Technical momentum — the stock has shown no ability to absorb positive fundamental news (Q3 beat, raised guidance) with upside price action, suggesting institutional distribution or ETF-driven selling is overwhelming fundamental buyers. MITIGATION: 3% position size limits downside impact; $43.50 stop-loss represents ~15% drawdown from $51.25 entry and aligns with book value support; $1.32B cash provides fundamental floor. The stock cannot go to zero without a catastrophic business failure that the balance sheet precludes for 6+ years.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is ACMR a halal stock?
No, ACM Research, Inc. (ACMR) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for ACMR?
ACM Research, Inc. (ACMR) has a Plutrex AI rating of 74.0/100 with a Buy consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is ACMR a good investment?
According to Plutrex AI, ACMR has a Buy rating (74.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in ACMR?
US stocks like ACMR can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. ElBarake provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in ACMR?
Plutrex AI identifies the main risks for ACMR by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.